DK1749517T3 - Stabil farmaceutiske sammensætning af linezolid form IV - Google Patents

Stabil farmaceutiske sammensætning af linezolid form IV

Info

Publication number
DK1749517T3
DK1749517T3 DK06250227T DK06250227T DK1749517T3 DK 1749517 T3 DK1749517 T3 DK 1749517T3 DK 06250227 T DK06250227 T DK 06250227T DK 06250227 T DK06250227 T DK 06250227T DK 1749517 T3 DK1749517 T3 DK 1749517T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
linezolid
linezolid form
stable pharmaceutical
patient
Prior art date
Application number
DK06250227T
Other languages
English (en)
Inventor
Ruth Tenengauzer
Minutza Leibovici
Ben-Zion Solomon
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36129715&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1749517(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Application granted granted Critical
Publication of DK1749517T3 publication Critical patent/DK1749517T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK06250227T 2005-07-20 2006-01-17 Stabil farmaceutiske sammensætning af linezolid form IV DK1749517T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70143805P 2005-07-20 2005-07-20

Publications (1)

Publication Number Publication Date
DK1749517T3 true DK1749517T3 (da) 2008-11-03

Family

ID=36129715

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06250227T DK1749517T3 (da) 2005-07-20 2006-01-17 Stabil farmaceutiske sammensætning af linezolid form IV

Country Status (15)

Country Link
US (1) US20070020329A1 (da)
EP (1) EP1749517B8 (da)
JP (1) JP2009501794A (da)
CN (1) CN101262853A (da)
AT (1) ATE400257T1 (da)
AU (1) AU2006277017A1 (da)
CA (1) CA2612481A1 (da)
DE (1) DE602006001699D1 (da)
DK (1) DK1749517T3 (da)
ES (1) ES2309920T3 (da)
HK (1) HK1097774A1 (da)
IL (1) IL188176A0 (da)
PL (1) PL1749517T3 (da)
PT (1) PT1749517E (da)
WO (1) WO2007018588A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007102082A1 (en) * 2006-03-09 2007-09-13 Glenmark Pharmaceuticals Limited High oxazolidinone content solid dosage forms
WO2011080570A2 (en) * 2009-12-29 2011-07-07 Micro Labs Limited Extended release pharmaceutical composition comprising linezolid and process for preparing the same
WO2012029074A2 (en) * 2010-09-02 2012-03-08 Hetero Research Foundation Pharmaceutical compositions of linezolid
CN102885788B (zh) * 2011-07-22 2016-06-29 重庆华邦制药有限公司 一种晶型稳定的利奈唑胺片及其制备方法
WO2013088389A1 (en) * 2011-12-14 2013-06-20 Alembic Pharmaceuticals Limited Linezolid premix
CN103099792B (zh) * 2012-12-10 2014-11-26 成都欣捷高新技术开发有限公司 一种高载药量、体外快速溶出的iv晶型利奈唑胺片的制备方法
CN103893138B (zh) * 2012-12-28 2017-09-29 成都国为生物医药有限公司 一种含有利奈唑胺晶型ⅲ的片剂
CN104370846B (zh) * 2013-08-15 2017-04-12 杭州华东医药集团新药研究院有限公司 制备利奈唑胺ⅳ晶型的方法
CN104622831B (zh) * 2013-11-06 2018-06-22 江苏豪森药业集团有限公司 一种口服片剂及其制备方法
CN104173303B (zh) * 2014-08-14 2017-01-11 杭州华东医药集团新药研究院有限公司 一种含有利奈唑胺的组合物及其制备方法
CN104586812A (zh) * 2014-12-25 2015-05-06 杭州华东医药集团新药研究院有限公司 一种含有利奈唑胺的组合物及其制备方法
EP3170864B1 (en) * 2015-11-17 2018-10-17 Borealis AG High flow tpo composition with excellent balance in mechanical properties for automotive interior
CN111675669A (zh) * 2020-05-15 2020-09-18 扬子江药业集团北京海燕药业有限公司 一种利奈唑胺结晶形式及其制备方法和药物组合物
CN118059106B (zh) * 2024-04-17 2024-06-28 山东新时代药业有限公司 一种利奈唑胺抗菌制剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
AR027261A1 (es) * 2000-02-02 2003-03-19 Upjohn Co Linezolid forma cristalina ii
US6444813B2 (en) 2000-02-02 2002-09-03 Pharmacia & Upjohn Company Linezolid-crystal form II
WO2001070225A2 (en) * 2000-03-22 2001-09-27 Pharmacia & Upjohn Company Oxazolidinone tablet formulation
US6514529B2 (en) * 2000-03-22 2003-02-04 Pharmacia & Upjohn Company Oxazolidinone tablet formulation
ES2803516T3 (es) * 2003-10-16 2021-01-27 Symed Labs Ltd Una forma cristalina de linezolid
US20060142283A1 (en) * 2004-06-29 2006-06-29 Judith Aronhime Crystalline form IV of linezolid

Also Published As

Publication number Publication date
HK1097774A1 (en) 2007-07-06
EP1749517B8 (en) 2008-10-22
AU2006277017A1 (en) 2007-02-15
PT1749517E (pt) 2008-09-29
WO2007018588A8 (en) 2008-05-08
EP1749517B1 (en) 2008-07-09
US20070020329A1 (en) 2007-01-25
IL188176A0 (en) 2008-03-20
DE602006001699D1 (de) 2008-08-21
ATE400257T1 (de) 2008-07-15
WO2007018588A1 (en) 2007-02-15
ES2309920T3 (es) 2008-12-16
CN101262853A (zh) 2008-09-10
CA2612481A1 (en) 2007-02-15
EP1749517A1 (en) 2007-02-07
JP2009501794A (ja) 2009-01-22
PL1749517T3 (pl) 2008-12-31

Similar Documents

Publication Publication Date Title
DK1749517T3 (da) Stabil farmaceutiske sammensætning af linezolid form IV
LTC1781298I2 (lt) Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui
AR110413A2 (es) Compuesto 5-cloro-n-((5s)-2-oxo-3-[4-(3-oxo-4-morfolinil)fenil]-1,3-oxazolidin-5-ilmetil)-2-tiofencarboxamida
GEP20135803B (en) Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
MX2009008439A (es) Nuevos inhibidores de la replicacion del virus de hepatitis c.
ATE410424T1 (de) Spirocyclische cyclohexan-derivate
DK2023918T3 (da) Cyclosporiner til behandlingen og forebyggelse af okulære lidelser
SE0401971D0 (sv) Piperidne derivatives
NO20072094L (no) Hette for medikamentavleveringsinnretning
NO20075111L (no) Farmasoytisk sammensetning
TW200716628A (en) Novel compounds
EA201100305A1 (ru) Лечение респираторных заболеваний
CY1112320T1 (el) Τιτλοδοτηση της ταπενταδολης
NO20064078L (no) Substituerte azetidinsammensetninger, deres fremstilling og anvendelse som medikamenter
GB0514463D0 (en) Use of pinolenic acid
EA201170753A1 (ru) Налмефена гидрохлорид дигидрат
SE0401342D0 (sv) Therapeutic compounds
SE0401970D0 (sv) Novel compounds
EA201170512A1 (ru) Композиция для перорального введения
CY1108196T1 (el) Αντιμικροβιακες φαρμακευτικες συνθεσεις χορηγουμενες απο το στομα
DE502007005902D1 (de) -methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate
RU2007122391A (ru) S-миртазапин для лечения приливов
TW200718698A (en) Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
SE0501903L (sv) Borföreningar användbara vid BNCT
UY29134A1 (es) Sulfonamidas sustituidas por derivados de bencimidazol, composiciones que la contienen, procedimiento de preparacion y aplicaciones